PKR drives neuropathology in a mouse model of Leigh syndrome
Melania Gonzalez-TorresiD, Patrizia Bianchi, Marcos Blanco-Ramos, Marta Luna-Sanchez, Patricia Prada-DacasaiD, Emma PuighermanaliD, Carla CanaliD, Laura CutandoiD, Stephanie LeiD, Alex Gella, Monica Girona, Laura Sanchez-Benito, Berta Armengol, Isabella AppiahiD, Joaquin Fernandez-Irigoyen, Mohammed Alkhatib, Leonard Feist, Gregory McElroy, Pawel Lisowski, Antonio del SoliD, Enrique Santamaria, Alessandro PrigioneiD, Elisenda SanziD, Albert QuintanaiD
Abstract
Mitochondrial dysfunction is increasingly recognized as a trigger of innate immune responses, yet whether these responses contribute to neurodegeneration remains poorly understood. Here, we uncover a cell-type-specific antiviral program in vulnerable GABAergic neurons of Ndufs4-deficient mice and human brain organoids modeling Leigh syndrome. Despite robust type I interferon responses, genetic ablation of innate immune mediators Ifnar1 or Sting1 fails to ameliorate disease progression. Instead, we identify the double-stranded RNA sensor protein kinase R (PKR) as a critical mediator of mitochondrial neuropathology. PKR associates with mitochondrial RNA, while its genetic deletion or silencing delays neurological decline, attenuates neuroinflammation, and extends survival without restoring mitochondrial respiration. PKR deletion also normalizes JNK signaling without detectable global translational repression, suggesting a noncanonical contribution to disease. Together, our findings reveal PKR-mediated antiviral RNA sensing as a pathogenic mechanism in mitochondrial complex I deficiency and highlight PKR as a candidate target for mitochondrial encephalopathies.
02 /Specification & Classification
Click any tag to browse matching papersReproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- MyD88 deficiency modestly attenuates disease in a Leigh syndrome mouse model while enrofloxacin accelerates disease
Allison Rose Hanaford, Elizaveta A. Olkhova, … Simon C. Johnson·Journal of Neuropathology & Experimental NeurologyPeer-reviewed·Sep 4, 2026
- IFNγ modestly contributes to disease progression in the Ndufs4(-/-) model of Leigh syndrome while IP10 is dispensable
A. R. Hanaford, A. Khanna, … S. C. Johnson·bioRxiv·Jul 9, 2023
- LRRK2 kinase activity restricts NRF2-dependent mitochondrial protection in microglia
Chi Gidley Weindel, Aja K. Coleman, … Robert O. Watson·The Journal of ImmunologyPeer-reviewed·Sep 4, 2025
- Leukocyte proliferation mediates disease pathogenesis in the Ndufs4(KO) mouse model of Leigh syndrome
J. Stokes, R. Bornstein, … S. C. Johnson·bioRxiv·Nov 11, 2021
- Peripheral macrophages causally contribute to disease onset and progression in the Ndufs4(KO) model of Leigh syndrome
A. Hanaford, A. Khanna, … S. C. Johnson·bioRxiv·Jan 27, 2023
- Interferon-γ signaling synergizes with LRRK2 in human neurons and microglia
Silvia De Cicco, Dina Ivanyuk, … Michela Deleidi·bioRxiv·Jan 30, 2020